Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Sophie Sérrière"'
Autor:
Georgine Accrombessi, Laurent Galineau, Clovis Tauber, Sophie Serrière, Esteban Moyer, Bruno Brizard, Anne-Marie Le Guisquet, Alexandre Surget, Catherine Belzung
Publikováno v:
Translational Psychiatry, Vol 12, Iss 1, Pp 1-10 (2022)
Abstract The different depressive disorders that exist can take root at adolescence. For instance, some functional and structural changes in several brain regions have been observed from adolescence in subjects that display either high vulnerability
Externí odkaz:
https://doaj.org/article/cbb60619e6ca44788630bdb86b62e592
Autor:
Laurent Galineau, Emmanuelle Claude, Zuhal Gulhan, Sylvie Bodard, Sophie Sérrière, Camille Dupuy, Jérémy Monteiro, Adeline Oury, Priscila Bertevello, Gabrielle Chicheri, Johnny Vercouillie, Lydie Nadal-Desbarats, Sylvie Chalon, Antoine Lefèvre, Patrick Emond
Publikováno v:
EJNMMI Radiopharmacy and Chemistry, Vol 9, Iss 1, Pp 1-12 (2024)
Abstract Background Selection of the most promising radiotracer candidates for radiolabeling is a difficult step in the development of radiotracer pharmaceuticals, especially for the brain. Mass spectrometry (MS) is an alternative to study ex vivo th
Externí odkaz:
https://doaj.org/article/e9cfcea52ce041edb14dbe373bbc56b9
Autor:
Steven Vetel, Laura Foucault-Fruchard, Claire Tronel, Frédéric Buron, Jackie Vergote, Sylvie Bodard, Sylvain Routier, Sophie Sérrière, Sylvie Chalon
Publikováno v:
Neural Regeneration Research, Vol 16, Iss 6, Pp 1099-1104 (2021)
To date there is no treatment able to stop or slow down the loss of dopaminergic neurons that characterizes Parkinson's disease. It was recently observed in a rodent model of Alzheimer's disease that the interaction between the a7 subtype of nicotini
Externí odkaz:
https://doaj.org/article/138dd4a75e494bb4a5296ec14240be22
Autor:
Clément Thomas MD, Johnny Vercouillie PhD, Aurélie Doméné, Clovis Tauber PhD, Michael Kassiou PhD, Denis Guilloteau PhD, Christophe Destrieux MD, PhD, Sophie Sérrière PhD, Sylvie Chalon PhD
Publikováno v:
Molecular Imaging, Vol 15 (2016)
Subarachnoid hemorrhage (SAH) can lead to delayed cerebral ischemia, which increases the rate of morbidity and mortality. The detection of microglial activation may serve as a biomarker for the identification of patients at risk of this deleterious c
Externí odkaz:
https://doaj.org/article/c96fbf9b602040dab1a0d15413dcb484
Autor:
Johnny, Vercouillie, Frédéric, Buron, Sophie, Sérrière, Nuno, Rodrigues, Zuhal, Gulhan, Agnès, Chartier, Gabrielle, Chicheri, Hamid, Marzag, Adeline, Oury, Nathalie, Percina, Sylvie, Bodard, Rajah, Ben Othman, Julie, Busson, Franck, Suzenet, Denis, Guilloteau, Mathieu, Marchivie, Patrick, Emond, Sylvain, Routier, Sylvie, Chalon
Publikováno v:
European journal of medicinal chemistry. 244
Age-related neurodegenerative diseases have in common the occurrence of cognitive impairment, a highly incapacitating process that involves the cholinergic neurotransmission system. The vesicular acetylcholine transporter (VAChT) positron emission to
Autor:
Steven, Vetel, Johnny, Vercouillie, Frédéric, Buron, Jackie, Vergote, Clovis, Tauber, Julie, Busson, Gabrielle, Chicheri, Sylvain, Routier, Sophie, Sérrière, Sylvie, Chalon
Publikováno v:
Molecular imaging and biology. 22(2)
The nicotinic acetylcholine alpha-7 receptors (α7R) are involved in a number of neuropsychiatric and neurodegenerative brain disorders such as Parkinson's disease (PD). However, their specific pathophysiologic roles are still unclear. In this contex
Autor:
Frédéric Boisson, Sophie Serriere, Liji Cao, Sylvie Bodard, Alessandro Pilleri, Lionel Thomas, Giancarlo Sportelli, Johnny Vercouillie, Patrick Emond, Clovis Tauber, Nicola Belcari, Jean-Luc Lefaucheur, David Brasse, Laurent Galineau
Publikováno v:
EJNMMI Physics, Vol 9, Iss 1, Pp 1-14 (2022)
Abstract Background Non-human primates (NHP) are critical in biomedical research to better understand the pathophysiology of diseases and develop new therapies. Based on its translational and longitudinal abilities along with its non-invasiveness, PE
Externí odkaz:
https://doaj.org/article/8916ac3552584ca8a4eca533833a1cd3
Autor:
Sophie, Sérrière, Clovis, Tauber, Johnny, Vercouillie, Denis, Guilloteau, Jean-Bernard, Deloye, Lucette, Garreau, Laurent, Galineau, Sylvie, Chalon
Publikováno v:
Nuclear medicine and biology. 41(1)
We examined whether [(18)F]LBT-999 ((E)-N-(4-fluorobut-2-enyl)2β-carbomethoxy-3β-(4'-tolyl)nortropane) is an efficient positron emission tomography (PET) tracer for the quantification of the dopamine transporter (DAT) in the healthy rat brain.PET s
Autor:
Anne-Claire Dupont, Nicolas Arlicot, Johnny Vercouillie, Sophie Serrière, Serge Maia, Frédérique Bonnet-Brilhault, Maria-Joao Santiago-Ribeiro
Publikováno v:
Pharmaceuticals, Vol 16, Iss 8, p 1127 (2023)
The metabotropic glutamate receptor subtype 5 (mGluR5) is a class C G-protein-coupled receptor (GPCR) that has been implicated in various neuronal processes and, consequently, in several neuropsychiatric or neurodevelopmental disorders. Over the past
Externí odkaz:
https://doaj.org/article/a0ef0e8112ad44b9bbb41668f183fdf8
Autor:
Anne-Claire Dupont, Sophie Serrière, Laurent Barantin, Johnny Vercouillie, Clovis Tauber, Valérie Gissot, Sylvie Bodard, Gabrielle Chicheri, Sylvie Chalon, Pr Frédérique Bonnet-Brilhault, Pr Maria-Joao Santiago-Ribeiro, Nicolas Arlicot
Publikováno v:
Translational Psychiatry, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract Altered glutamate signaling is thought to be involved in a myriad of psychiatric disorders. Positron emission tomography (PET) imaging with [18F]FPEB allows assessing dynamic changes in metabotropic glutamate receptor 5 (mGluR5) availability
Externí odkaz:
https://doaj.org/article/4fd6a35337044f71b987943cef746800